ZA966744B - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
ZA966744B
ZA966744B ZA9606744A ZA966744A ZA966744B ZA 966744 B ZA966744 B ZA 966744B ZA 9606744 A ZA9606744 A ZA 9606744A ZA 966744 A ZA966744 A ZA 966744A ZA 966744 B ZA966744 B ZA 966744B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
wounds
healing
fragment
promoting
Prior art date
Application number
ZA9606744A
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of ZA966744B publication Critical patent/ZA966744B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Eye Examination Apparatus (AREA)
  • Prostheses (AREA)
  • Invalid Beds And Related Equipment (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9606744A 1995-08-09 1996-08-08 Pharmaceutical composition. ZA966744B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9516287A GB2304047A (en) 1995-08-09 1995-08-09 Pharmaceutical compositions containing cytokines

Publications (1)

Publication Number Publication Date
ZA966744B true ZA966744B (en) 1998-02-09

Family

ID=10778967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606744A ZA966744B (en) 1995-08-09 1996-08-08 Pharmaceutical composition.

Country Status (13)

Country Link
US (2) US6387364B1 (fr)
EP (1) EP0871473B1 (fr)
JP (1) JP4050317B2 (fr)
AT (1) ATE229814T1 (fr)
AU (1) AU719089B2 (fr)
CA (1) CA2229078C (fr)
DE (1) DE69625516T2 (fr)
DK (1) DK0871473T3 (fr)
ES (1) ES2187665T3 (fr)
GB (1) GB2304047A (fr)
PT (1) PT871473E (fr)
WO (1) WO1997005894A1 (fr)
ZA (1) ZA966744B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941108B1 (fr) * 1996-12-04 2002-10-16 Renovo Limited Guerison de blessures et traitement de la fibrose
WO1998033516A1 (fr) * 1997-02-05 1998-08-06 Schering Corporation Utilisation de il-4 ou de il-10 afin de traiter la glomerulonephrite proliferative
CA2384076A1 (fr) * 1999-09-08 2001-03-15 Schering Corporation Nouvelles utilisations des recepteurs ccr6 de mammiferes et reactifs associes
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
ATE516820T1 (de) 2000-09-29 2011-08-15 Schering Corp Pegyliertes interleukin 10
US20030148952A1 (en) * 2001-10-18 2003-08-07 Crombleholme Timothy M. Methods and materials for the recruitment of endothelial cells
NZ573737A (en) * 2003-07-15 2011-06-30 Univ Bar Ilan Methods and pharmaceutical compositions for healing wounds comprising a PKC modulator
DK1651161T3 (da) 2003-08-07 2012-01-30 Healor Ltd Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
GB0524103D0 (en) 2005-11-26 2006-01-04 Medical Res Council Healing
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
JP5960944B2 (ja) 2006-11-15 2016-08-02 コーダ セラピューティクス， インコーポレイテッド 創傷治癒のための改善された方法および組成物
CN101835486B (zh) * 2007-07-30 2012-12-12 希尔洛有限公司 用于治疗创伤的药物组合物以及相关方法
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
EP2234656A2 (fr) 2007-12-21 2010-10-06 Coda Therapeutics, Inc. Dispositifs médicaux améliorés
JP2011507862A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用
JP2011507856A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用
WO2009120799A2 (fr) * 2008-03-25 2009-10-01 Paloma Pharmaceuticals, Inc. Procédés de traitement de troubles fibrotiques
EP3348281B1 (fr) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Production d'il-10 mono- et di-pégylé et ses utilisations
CN102325789A (zh) * 2009-02-24 2012-01-18 希尔洛有限公司 用于治疗痤疮和其它病症的内脂素治疗药物
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
EP2691515A2 (fr) * 2011-03-31 2014-02-05 President and Fellows of Harvard College Population unique de lymphocytes t régulateurs qui régulent la régénération de tissu et la cicatrisation des plaies
AU2013263502B2 (en) * 2012-05-18 2018-02-08 Otago Innovation Limited Combination treatments and compositions for wound healing
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
HK1226308A1 (zh) 2013-08-30 2017-09-29 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
KR20170068553A (ko) 2014-10-14 2017-06-19 아르모 바이오사이언시스 인코포레이티드 인터류킨-15 조성물 및 이의 용도
JP6675394B2 (ja) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害の治療のためにインターロイキン−１０を使用する方法
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
DE3889479T2 (de) 1987-02-27 1994-12-22 Eastman Kodak Co Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung.
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
DK0526544T3 (da) 1990-04-11 1999-06-21 Brigham & Womens Hospital Terapeutiske anvendelser af actinbindende forbindelser
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
AU8647991A (en) 1991-08-26 1993-03-16 State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB9207732D0 (en) * 1992-04-06 1992-05-27 Isis Innovation Wound repair
WO1994027640A1 (fr) * 1993-05-27 1994-12-08 The Regents Of The University Of Michigan Procede de traitement et de prevention des lesions du poumon induites par les complexes immuns
IL110413A0 (en) 1993-07-26 1994-10-21 Schering Corp Agonists and antagonists of human interleukin-10
JP4083794B2 (ja) * 1994-03-29 2008-04-30 レノボ・リミテッド 創傷の治癒
EP1621206A1 (fr) * 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Cytokines chimeres et leur utilisation
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
GB2304045A (en) * 1995-08-04 1997-03-12 Univ Manchester Betaglycan compositions for promoting the healing of wounds and fibrotic diseases

Also Published As

Publication number Publication date
JP4050317B2 (ja) 2008-02-20
DE69625516T2 (de) 2003-09-25
GB9516287D0 (en) 1995-10-11
CA2229078C (fr) 2010-04-20
CA2229078A1 (fr) 1997-02-20
EP0871473B1 (fr) 2002-12-18
DK0871473T3 (da) 2003-04-14
JPH11510505A (ja) 1999-09-14
PT871473E (pt) 2003-03-31
ATE229814T1 (de) 2003-01-15
WO1997005894A1 (fr) 1997-02-20
AU6666096A (en) 1997-03-05
AU719089B2 (en) 2000-05-04
EP0871473A1 (fr) 1998-10-21
GB2304047A (en) 1997-03-12
US6387364B1 (en) 2002-05-14
US20020128447A1 (en) 2002-09-12
ES2187665T3 (es) 2003-06-16
US7052684B2 (en) 2006-05-30
DE69625516D1 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
GB9516287D0 (en) Pharmaceutical compositon
CA2054752A1 (fr) Composition pharmaceutique comprenant de la loratadine, de l'ibuprofene et de la pseudoephedrine
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
GB9521608D0 (en) Pharmaceutical composition
SE9603725D0 (sv) New teatment
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
ZA966578B (en) Pharmaceutical composition.
AU1576999A (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
CA2163118A1 (fr) Fractions d'acide aurintricarboxylique et analogues avec activite anti-angiogenique; methodes d'utilisation
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
AU2807492A (en) Use of misoprostol for the treatment of allergy
CA2227711A1 (fr) Metabolites d'acide thioctique et methodes d'utilisation
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
GB9516073D0 (en) Pharmaceutical composition
WO1997007136A3 (fr) Composition pharmaceutique contenant des inhibiteurs de l'inteferon gamma
IL138709A0 (en) METHODS FOR PROMOTING THE HEALING OF CUTANEOUS WOUNDS AND ULCERS USING COMPOSITIONS OF α-D-GLUCANS
WO1994018988A3 (fr) Compositions pharmaceutiques de traitement de maladies inflammatoires ou immunologiques et procede de traitement desdites maladies
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
AU7066794A (en) Hyaluronic acid fragments and their therapeutic use
GB9616549D0 (en) Therapeutic product and its use
GB9723824D0 (en) Cytostatic agents